Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Vijenthira · SciRah

Researcher profile · Semantic Scholar

A. Vijenthira

Share profile

A. Vijenthira — researcher profile on SciRah

h-index: 11
Works: 99
Citations: 963

Most-cited papers

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
A. Vijenthira, I. Gong, Thomas A. Fox, Stephen Booth +15 more
2020Blood558 citations Open access
Semantic Scholar
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
A. Vijenthira, I. Gong, S. Betschel, M. Cheung +1 more
2021Blood Advances110 citations Open access
Semantic Scholar
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
I. Gong, A. Vijenthira, M. Powis, A. Calzavara +7 more
2022JAMA Oncology49 citations Open access
Semantic Scholar
Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome
A. Vijenthira, Rebecca Starkman, Yulia Lin, S. Stanworth +5 more
2022Transfusion27 citations
Semantic Scholar
COVID‐19 vaccine response in patients with hematologic malignancy: A systematic review and meta‐analysis
I. Gong, A. Vijenthira, S. Betschel, L. Hicks +1 more
2022American journal of hematology/oncology26 citations Open access
Semantic Scholar
Predictors of intensive care unit admission in patients with hematologic malignancy
A. Vijenthira, Nicholas Chiu, D. Jacobson, Zoey Freedman +4 more
2020Scientific Reports26 citations Open access
Semantic Scholar
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
A. Vijenthira, K. Chan, M. Cheung, A. Prica
2020The Lancet Haematology23 citations
Semantic Scholar
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
A. Vijenthira, D. Premkumar, J. Callum, Yulia Lin +5 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis16 citations
Semantic Scholar
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma
A. Vijenthira, J. Kuruvilla, M. Crump, M. Jain +1 more
2022Journal of Clinical Oncology15 citations
Semantic Scholar
The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review
A. Suleman, A. Vijenthira, A. Berlin, A. Prica +1 more
2022Current Oncology14 citations Open access
Semantic Scholar
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
A. Vijenthira, L. Mozessohn, C. Nagamuthu, Ning Liu +4 more
2022The Journal of the National Comprehensive Cancer Network13 citations
Semantic Scholar
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies.
C. E. Harris, A. Vijenthira, Yeu-Ong Shin, L. Baden +2 more
2023American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting8 citations
Semantic Scholar
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia
A. Vijenthira, Virginia Volpe, A. Sekar, Roberta Santos Azevedo +13 more
2024Blood Advances7 citations Open access
Semantic Scholar
Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy
A. Vijenthira, J. Kuruvilla, A. Prica
2021Bone Marrow Transplantation7 citations
Semantic Scholar
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.
S. Bhella, Allison M. Wilkin, K. Hueniken, A. Vijenthira +19 more
2024Vaccine6 citations Open access
Semantic Scholar
Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience
A. Suleman, A. Vijenthira, ZhihuiAmy Liu, Truong Tran +3 more
2023JCO Oncology Practice6 citations
Semantic Scholar
Factors Associated with Timely COVID-19 Vaccination in a Population-based Cohort of Patients with Cancer.
M. Powis, R. Sutradhar, Aditi Patrikar, M. Cheung +6 more
2022Journal of the National Cancer Institute5 citations Open access
Semantic Scholar
Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?
A. Vijenthira, A. Wilton, S. Lee, G. Tang +3 more
2024British Journal of Haematology4 citations Open access
Semantic Scholar
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma
A. Vijenthira, A. Calzavara, C. Nagamuthu, Y. Kaliwal +6 more
2024Blood Advances4 citations Open access
Semantic Scholar
Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy.
C. Buchan, Gerard Agbayani, K. Hueniken, A. Vijenthira +24 more
2025Transplantation and Cellular Therapy3 citations
Semantic Scholar
Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study.
Inna Y. Gong, A. Vijenthira, Z. Ante, A. Calzavara +8 more
2025The Journal of the National Comprehensive Cancer Network3 citations
Semantic Scholar
COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis
Inna Y. Gong, A. Vijenthira, S. Betschel, Lisa K. Hicks +1 more
2021Blood3 citations Open access
Semantic Scholar
Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma
Davidson Zhao, Noémie Lang, Ting Liu, V. Shelton +17 more
2025JCO Precision Oncology2 citations Open access
Semantic Scholar
Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis
Nattinee Wattakiyanon, M. Aminilari, X. Ye, U. Metser +12 more
2025Advances in Radiation Oncology2 citations Open access
Semantic Scholar
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Ho-Ang Tuan, Matthew C. Cheung, David N. Juurlink, K. Chan +7 more
2025British Journal of Haematology2 citations Open access
Semantic Scholar
Rate of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated with First-Line Bendamustine Rituximab and Rituximab Maintenance
J. Rangel-Patiño, J. Kuruvilla, A. Prica, R. Kridel +6 more
2024Blood2 citations
Semantic Scholar
A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada
Tiana Kordbacheh, A. Prica, K. Chan, M. Aminilari +14 more
2024Blood2 citations
Semantic Scholar
Very late relapse in Hodgkin lymphoma: Characterizing an understudied population.
H. Cherniawsky, Esther Ting, J. Zhang, Wei Xu +8 more
2023Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
Frailty Impact on Outcomes of Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study
A. Prica, T. Coley, R. Aitken, A. Vijenthira +10 more
2023Blood2 citations Open access
Semantic Scholar
The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study
Tuan Hoang, M. Cheung, K. Chan, C. Lau +7 more
2022Blood2 citations Open access
Semantic Scholar
Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma
Tiana Kordbacheh, K. Chan, Michael Crump, Z. Ante +13 more
2026Blood Advances1 citations Open access
Semantic Scholar
Clinical characteristics and disease outcomes of primary bone lymphoma in the rituximab era: a retrospective study from the Princess Margaret Cancer Center, Toronto, Canada
C. Abeyakoon, Esther Ting, Sahar Khan, M. Maganti +11 more
2025Leukemia and Lymphoma1 citations
Semantic Scholar
Distinct characteristics and social determinants in adult T‐cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada
T. Aoki, M. Salib, A. Suleman, N. Ghanem +8 more
2025British Journal of Haematology1 citations Open access
Semantic Scholar
ASSOCIATION OF BRIDGING THERAPY WITH RESPONSE AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA RECEIVING THIRD LINE CAR‐T
I. Gong, M. Jeeva, K. Hueniken, M. Aminilari +17 more
2025Hematological Oncology1 citations
Semantic Scholar
Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy
C. Abeyakoon, S. Bhella, K. Hueniken, R. Aitken +14 more
2025Blood neoplasia1 citations
Semantic Scholar
Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy
C. Abeyakoon, S. Bhella, K. Hueniken, R. Aitken +14 more
2024Blood1 citations
Semantic Scholar
COVID-19 Humoral Immunity Improves with Third and Subsequent Vaccine Doses in Patients with Plasma Cell Dyscrasias, Particularly in Those Receiving antiCD38 Therapy
S. Bhella, Allison M. Wilkin, K. Hueniken, A. Vijenthira +21 more
2024Blood1 citations
Semantic Scholar
Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study
Samantha J Mayo, K. Edelstein, Lori J. Bernstein, T. Coley +12 more
2023Blood1 citations Open access
Semantic Scholar
Isolated Thrombocytopenia in Older Adults Is Associated with the Diagnosis of Hematologic Malignancy: A Population-Based Study
A. Vijenthira, A. Wilton, Grace H. Tang, T. Gomes +1 more
2022Blood1 citations Open access
Semantic Scholar
Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study
A. Vijenthira, L. Mozessohn, C. Nagamuthu, Ning Liu +4 more
20201 citations
Semantic Scholar
Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients
A. Vijenthira, I. Gong, Thomas A. Fox, S. Booth +15 more
2020Blood1 citations Open access
Semantic Scholar
COST‐EFFECTIVENESS AND COST‐UTILITY ANALYSIS OF MULTIPLE TREATMENT STRATEGIES USING ABVD AND/OR BEACOPP IN THE TREATMENT OF ADVANCED‐STAGE HODGKIN LYMPHOMA
A. Prica, A. Vijenthira, K. Chan, Matthew C. Cheung
2019Hematological Oncology1 citations Open access
Semantic Scholar
Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma
A. Vijenthira, K. Chan, M. Cheung, A. Prica
2018Blood1 citations
Semantic Scholar
ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis
A. Vijenthira, M. Cheung, C. Phua, K. Chan +3 more
20161 citations
Semantic Scholar
Putative Clonal Evolution in a PHF6‐Mutant T/NK‐Cell Lymphoproliferative Disorder With Selective Loss of a STAT5B‐Mutant Subclone
M. Turingan, Cuihong Wei, Nihad Almokhtar, A. Vijenthira +1 more
2026eJHaem0 citations Open access
Semantic Scholar
Management and Outcomes for Hodgkin's Lymphoma Patients with Partial Metabolic Response after First-Line Systemic Therapy.
Donna Liao, M. Aminilari, Xiang Y. Ye, U. Metser +12 more
2026Practical Radiation Oncology0 citations Open access
Semantic Scholar
The Burden of Cardiovascular Disease in Lymphoma Survivors
Christopher Yu, Yue Chen, G. Halajha, A. Prica +5 more
2026JACC: Advances0 citations Open access
Semantic Scholar
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
S. Bhella, Gerard Agbayani, K. Hueniken, A. Vijenthira +23 more
2026Blood Advances0 citations
Semantic Scholar
Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma
Carolyn Owen, Christopher Lemieux, Mark Bosch, Kelly Davison +7 more
2026Current Oncology0 citations Open access
Semantic Scholar
The association of thrombocytopenia with haematological malignancy
A. Vijenthira, Henrik Frederiksen, M. Sholzberg
2026British Journal of Haematology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Prica×28
Invite
A. Prica — researcher profile on SciRah
S. Bhella×16
Invite
S. Bhella — researcher profile on SciRah
R. Kridel×14
Invite
R. Kridel — researcher profile on SciRah
V. Kukreti×13
Invite
V. Kukreti — researcher profile on SciRah

×11

Invite

M. Cheung — researcher profile on SciRah

Michael Crump×9

Invite

Michael Crump — researcher profile on SciRah

Invite

Chloe Yang — researcher profile on SciRah

Invite

L. Hicks — researcher profile on SciRah

Invite

K. Hueniken — researcher profile on SciRah

Invite

I. Gong — researcher profile on SciRah

L. Mozessohn×6

Invite

L. Mozessohn — researcher profile on SciRah

Invite

K. Chan — researcher profile on SciRah